Short-term intravenous insulin infusion is associated with reduced expression of NADPH oxidase p47(phox) subunit in monocytes from type 2 diabetes patients

Fundam Clin Pharmacol. 2013 Dec;27(6):669-71. doi: 10.1111/j.1472-8206.2012.01057.x. Epub 2012 Jul 10.

Abstract

Hyperglycemia is a well-known inducing factor of oxidative stress through activation of NADPH oxidase. In addition to its plasma glucose lowering effect, insulin may also have antioxidant activity and was shown to downregulate NADPH oxidase expression in vitro. In this study, we show that a short-term (3-day) intravenous insulin infusion in patients with type 2 diabetes induces normalization of both glycemia and mRNA expression of circulating monocyte p47(phox) subunit.

Keywords: NADPH oxidase; diabetes; insulin; monocytes.

Publication types

  • Clinical Trial

MeSH terms

  • Blood Glucose / drug effects
  • Case-Control Studies
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Gene Expression Regulation / drug effects
  • Humans
  • Hypoglycemic Agents / administration & dosage
  • Hypoglycemic Agents / pharmacology*
  • Infusions, Intravenous
  • Insulin / administration & dosage
  • Insulin / pharmacology*
  • Middle Aged
  • Monocytes / drug effects
  • Monocytes / metabolism
  • NADPH Oxidases / genetics*
  • RNA, Messenger / metabolism
  • Time Factors

Substances

  • Blood Glucose
  • Hypoglycemic Agents
  • Insulin
  • RNA, Messenger
  • NADPH Oxidases
  • neutrophil cytosolic factor 1